E
Elaine F. Reed
Researcher at University of California, Los Angeles
Publications - 295
Citations - 14308
Elaine F. Reed is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Transplantation & Human leukocyte antigen. The author has an hindex of 56, co-authored 263 publications receiving 12433 citations. Previous affiliations of Elaine F. Reed include Papworth Hospital & University of California.
Papers
More filters
Journal ArticleDOI
Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection
Susan Stewart,Michael C. Fishbein,G.I. Snell,Gerald J. Berry,Annette Boehler,Margaret Burke,A. Glanville,F. Kate Gould,Cynthia Magro,Charles C. Marboe,K. McNeil,Elaine F. Reed,Nancy L. Reinsmoen,John P. Scott,Sean M. Studer,Henry D. Tazelaar,John Wallwork,G.P. Westall,Martin Zamora,Adriana Zeevi,Samuel A. Yousem +20 more
TL;DR: This article summarizes the revised consensus classification of lung allograft rejection and recommends the evaluation of antibody-mediated rejection, recognizing that this is a controversial entity in the lung, less well developed and understood than in other solid-organ grafts, and with no consensus reached on diagnostic features.
Journal ArticleDOI
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Brian D. Tait,Caner Süsal,Howard M. Gebel,Peter Nickerson,Andrea A. Zachary,Frans H.J. Claas,Elaine F. Reed,Robert A. Bray,Patricia Campbell,Jeremy R. Chapman,P. Toby Coates,Robert B. Colvin,Emanuele Cozzi,Ilias I.N. Doxiadis,Susan V. Fuggle,John S. Gill,Denis Glotz,Nils Lachmann,Thalachallour Mohanakumar,Nicole Suciu-Foca,Suchitra Sumitran-Holgersson,Kazunari Tanabe,Craig J. Taylor,Dolly B. Tyan,Angela C Webster,Adriana Zeevi,Gerhard Opelz +26 more
TL;DR: A group of laboratory and clinical experts in the field of transplantation was convened to prepare a consensus report and make recommendations on the use of this new technology based on both published evidence and expert opinion.
Journal ArticleDOI
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
Alexandre Loupy,Mark Haas,Kim Solez,Lorraine C. Racusen,Denis Glotz,Daniel Serón,Brian J. Nankivell,Robert B. Colvin,Marjan Afrouzian,Enver Akalin,Nada Alachkar,Serena M. Bagnasco,Jan U. Becker,Lynn D. Cornell,Cinthia B. Drachenberg,Duska Dragun,H. de Kort,Ian W. Gibson,Edward S. Kraus,Carmen Lefaucheur,Ch. Legendre,Helen Liapis,Thangamani Muthukumar,Volker Nickeleit,Babak J. Orandi,Walter D. Park,Marion Rabant,Parmjeet Randhawa,Elaine F. Reed,Candice Roufosse,Surya V. Seshan,Banu Sis,Harsharan K. Singh,Carrie A. Schinstock,Anat R. Tambur,A. Zeevi,Michael Mengel +36 more
TL;DR: Improved definitions of TCMR and ABMR in pancreas transplants with specification of vascular lesions and prospects for defining a vascularized composite allograft rejection classification are included.
Journal ArticleDOI
Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.
Paul J Michaels,Maria L. Espejo,Jon A. Kobashigawa,Juan C. Alejos,C. Burch,Takemoto S,Elaine F. Reed,Michael C. Fishbein +7 more
TL;DR: Humoral rejection is a clinicopathologic entity with a high incidence in women and is associated with acute hemodynamic compromise, accelerated transplant coronary artery disease and death.
Journal ArticleDOI
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Jon A. Kobashigawa,María G. Crespo-Leiro,Stephan M. Ensminger,Hermann Reichenspurner,Annalisa Angelini,Gerald J. Berry,Margaret Burke,Lawrence S.C. Czer,Nicola E. Hiemann,Abdallah G. Kfoury,Donna Mancini,Paul Mohacsi,Jignesh Patel,Naveen L. Pereira,Jeffrey L. Platt,Elaine F. Reed,Nancy L. Reinsmoen,E. Rene Rodriguez,Marlene L. Rose,Stuart D. Russell,Randy Starling,Nicole Suciu-Foca,Jose A. Tallaj,David O. Taylor,Adrian B. Van Bakel,Lori J. West,Adriana Zeevi,Andreas Zuckermann +27 more
TL;DR: A clinical definition for AMR (cardiac dysfunction and/or circulating donor-specific antibody) was no longer believed to be required due to recent publications demonstrating that asymptomatic (no cardiac dysfunction) biopsy-proven AMR is associated with subsequent greater mortality and greater development of cardiac allograft vasculopathy.